Experienced in Angiosarcoma

Dr. Vilija N. Avizonis

Radiation Oncology
5171 South Cottonwood Street, Suite 610, 
Murray, UT 
Accepting New Patients
Offers Telehealth
40 Years of Experience
Experienced in Angiosarcoma
5171 South Cottonwood Street, Suite 610, 
Murray, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vilija Avizonis is a Radiation Oncologist in Murray, Utah. Dr. Avizonis has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Thymic Epithelial Tumor, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Avizonis is currently accepting new patients.

Her clinical research consists of co-authoring 6 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of New Mexico School Of Medicine, 1986
Residency
LDS Hospital/aka Latter Day Saints Hospital
Specialties
Radiation Oncology
Licenses
Radiology in UT
Board Certifications
American Board Of Radiology
Fellowships
The University of Iowa Hospitals & Clinics
Hospital Affiliations
Riverton Hospital
Intermountain Medical Center
Utah Valley Hospital
LDS Hospital
American Fork Hospital
McKay Dee Hospital
St George Regional Hospital
Cedar City Hospital
Languages Spoken
English
Lithuanian
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Steward Health Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Intermountain Health Cancer Center - Murray
5171 South Cottonwood Street, Suite 610, Murray, UT 84107
Other Locations
Utah Valley Clinic - Radiation Oncology
395 West Cougar Boulevard, Suite 106, Provo, UT 84604
Radiation Oncology - Logan
Logan, UT 84341

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
View 6 Less Clinical Trials

6 Total Publications

Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer.
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer.
Journal: American journal of clinical oncology
Published: February 04, 2025
Similar Doctors
Distinguished in Angiosarcoma
Dr. Jay A. Clark
Radiation Oncology
Distinguished in Angiosarcoma
Dr. Jay A. Clark
Radiation Oncology

Ihc Health Services Inc

395 W Bulldog Blvd, 
Provo, UT 
 (30.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jay Clark is a Radiation Oncologist in Provo, Utah. Dr. Clark is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Angiosarcoma, Astrocytoma, Gliosarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Clark is currently accepting new patients.

Advanced in Angiosarcoma
Dr. Brandon M. Barney
Radiation Oncology
Advanced in Angiosarcoma
Dr. Brandon M. Barney
Radiation Oncology

Radiation Oncology - American Fork

American Fork, UT 
 (17.1 miles away)
801-855-4100
Experience:
18+ years
Languages Spoken:
English, Portuguese
See accepted insurances
Offers Telehealth

Brandon Barney is a Radiation Oncologist in American Fork, Utah. Dr. Barney has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Angiosarcoma, Melanoma of the Eye, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Advanced in Angiosarcoma
Dr. Ying J. Hitchcock
Radiation Oncology
Advanced in Angiosarcoma
Dr. Ying J. Hitchcock
Radiation Oncology

Huntsman Cancer Institute

1950 Circle Of Hope Drive, 
Salt Lake City, UT 
 (8.4 miles away)
801-581-2121
Experience:
32+ years
Languages Spoken:
English, Mandarin
See accepted insurances
Offers Telehealth

Ying Hitchcock is a Radiation Oncologist in Salt Lake City, Utah. Dr. Hitchcock has been practicing medicine for over 32 years and is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Tongue Cancer, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Undifferentiated Pleomorphic Sarcoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Avizonis's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 42 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile